Welcome to the Medtronic plc Q2 2025 Earnings Conference Call!
A Fun and Informative Morning Ahead
Good morning, everyone! Today, we have an exciting lineup of speakers for our Q2 2025 Earnings Conference Call. From Geoff Martha, our Chairman and CEO, to Brad Welnick, our VP of Investor Relations, we have a diverse group of leaders ready to share insights on our latest financial performance.
Meet the Conference Call Participants
Let me introduce you to some of the key players on today’s call:
- Geoff Martha – Chairman and CEO
- Gary Corona – Interim CFO
- Brad Welnick – VP, IR
- Que Dallara – EVP and President, Diabetes Operating Unit
- Sean Salmon – EVP and President, Cardiovascular Portfolio
- Mike Marinaro – EVP and President, Medical Surgical Portfolio and Surgical Operating Unit
- Brett Wall – EVP and President, Neuroscience
We have a packed agenda and some exciting updates to share, so let’s dive right in to the discussion!
Impact on You
As a Medtronic shareholder, the information shared in today’s conference call can give you valuable insights into the company’s financial health and future prospects. Understanding the latest earnings and strategic direction can help you make informed decisions about your investments in Medtronic.
Global Impact
Medtronic plays a significant role in the healthcare industry worldwide. Any updates or announcements made during the conference call can have ripple effects on healthcare systems, medical technologies, and patient care around the globe. Stay tuned to see how Medtronic’s innovations are shaping the future of healthcare on a global scale.
In Conclusion
Thank you for joining us today for the Medtronic plc Q2 2025 Earnings Conference Call. We hope you found the discussions insightful and engaging. As we continue our journey towards innovation and growth, we are grateful for your continued support and investment in our mission to improve lives through healthcare technology. Have a fantastic day!
